A community for people who want to remain as healthy as possible as we age.

At the Republican convention, drug maker lobbies for more coverage of obesity drugs

(STAT) The main hall at the Republican National Convention has been ringing all week with talk about terrorism, immigration, and national security.
But in a side venue on Wednesday, a small crowd gathered to talk about a more intimate topic: obesity.
Pharma giant Novo Nordisk cosponsored the “Rethink Obesity” panel here, and plans to cohost a similar event during the Democratic convention next week in Philadelphia. The goal: To push lawmakers to enact a bill, pending in Congress, that would lift a longstanding ban on Medicare paying for obesity medication.
[Click the title, above, to post a comment.]


Post a Comment

Please do not give advice. We can best help each other by telling what works for us, not what we think someone else should do.